Molina R, Jiménez E, Macarulla, et al. T. A cross-sectional observational study to establish the association between ECOG performance status and age and administration of doublet or triplet chemotherapy containing Xeloda® (capecitabine) in advanced gastric cancer patients. Eur J Oncol Env Hea [Internet]. 2014 Jun. 4 [cited 2025 Feb. 23];18(4):173-80. Available from: https://mattioli1885journals.com/index.php/EJOEH/article/view/2443